Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline and Entacapone in Advanced Parkinson's Disease
NCT00199394Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Istradefylline in Parkinson's disease (PD) (3 arms), sponsored by Kyowa Kirin. Primary endpoint: Percentage of awake time spent in the OFF state at 16 weeks. Started Nov 2004; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00199394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199394.